Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination
NCT03393377
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Atherosclerosis
Interventions
DRUG:
fluvastatin 10 mg and valsartan 20 mg
DRUG:
placebo
Sponsor
University Medical Centre Ljubljana